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Abstract: The scaffolds made of polycaprolactone (PCL) are actively employed in different areas
of biology and medicine, especially in tissue engineering. However, the usage of unmodified PCL
is significantly restricted by the hydrophobicity of its surface, due to the fact that its inert surface
hinders the adhesion of cells and the cell interactions on PCL surface. In this work, the surface of PCL
nanofibers is modified by Ar/CO2/C2H4 plasma depositing active COOH groups in the amount of
0.57 at % that were later used for the immobilization of platelet-rich plasma (PRP). The modification
of PCL nanofibers significantly enhances the viability and proliferation (by hundred times) of human
mesenchymal stem cells, and decreases apoptotic cell death to a normal level. According to X-ray
photoelectron spectroscopy (XPS), after immobilization of PRP, up to 10.7 at % of nitrogen was
incorporated into the nanofibers surface confirming the grafting of proteins. Active proliferation and
sustaining the cell viability on nanofibers with immobilized PRP led to an average number of cells
of 258 ± 12.9 and 364 ± 34.5 for nanofibers with ionic and covalent bonding of PRP, respectively.
Hence, our new method for the modification of PCL nanofibers with PRP opens new possibilities for
its application in tissue engineering.
Keywords: polycaprolactone; nanofibers; COOH plasma; platelet-rich plasma; cell viability;
PRP immobilization
1. Introduction
In the last few decades, attention was drawn to biodegradable polycaprolactone (PCL) nanofibers
for its usage in tissue engineering due to their outstanding properties [1]. PCL is a semicrystalline,
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white-colored, bioresorbable polymer belonging to aliphatic polyesters. The PCL homopolymer has
total degradation time of 2–4 years in the body, depending on the starting molecular weight used for
the implant [2]. However, PCL as hydrophobic polyester has limited use, especially in a predominantly
hydrophilic bioenvironment for tissue engineering. Its modification with hydrophilic synthetic and
bio-polymers opens new horizons for its applications [3]. Compared to more expensive gelatin or
collagen nanofibers, PCL has better mechanical properties, whereas if we compare PCL with Nylon
6 (a semicrystalline polyamide), the latter one has poor biodegradability. Oligomers of Nylon 6 are
biodegradable, but not polymers [4]. It should be noted that this material is not sufficiently suitable
for maintaining cell adhesion, proliferation, and differentiation, due to the hydrophobic nature of
its surface. This drawback can be overcome by surface modification of PCL nanofibers leading to
increasing biocompatibility of the material [5–7].
The plasma deposition of functional thin layers is a method could be chosen to enhance the
biocompatibility of the nanofiber surface [8]. The functional groups (COOH, NH2, OH, etc.) increase
the wettability and surface free energy of the nanofibers and, moreover, reactive surface groups can
be used for the immobilization of biomolecules [9]. The plasma-deposited thin layers are used to
immobilize antibodies, growth factors, and peptides, as this robust, environmentally friendly technique
is substrate-independent and particularly efficient [10,11].
In order to use the nanofibrous mats for regenerative medicine, the substrates should enhance the
functional activity of adhered cells, or attract the cells into the wounded area [12,13]. Tissue engineering
aimed at replacement or restoration of damaged tissues with synthetic structures are designed to mimic
the extracellular matrix (ECM). As cell adhesion and viability can be ultimately improved if the surface
of nanofibers is functionalized with vital biological proteins, peptides, and growth factors. It would
be beneficial to combine the plasma deposition of reactive groups on nanofibers with the robust
immobilization of vital biomolecules to significantly increase the biocompatibility of the nanofibrous
mats [14–17]. For instance, in order to enhance the osteogenic differentiation of mesenchymal stem
cells (MSCs), PCL scaffolds were modified with fibronectin and hyaluronic acid [18,19]. Collagen and
vascular epidermal growth factor (VEGF) immobilization are often used for stimulation of angiogenesis
in the wounded area [20].
Recently, platelet-rich plasma (PRP) has been actively applied in the therapy of burns, acute and
chronic disruptions of the musculoskeletal system, dental implants, the therapy of periodontal tissues
disease [21,22], and dermatology [23]. The efficiency of PRP is related to the high concentration of
bioactive molecules and growth factors. These biomolecules are released owing to the destruction of
thrombocytes. The mixture of active molecules includes multiple growth factors such as epidermal
growth factor, basic fibroblast-derived growth factor, vascular endothelial growth factor, insulin-like
growth factor-1, platelet derived growth factor, transforming growth factor beta 1, adhesion
molecules-vascular cell adhesion molecule-1, intercellular adhesion molecule-1; protease inhibitors,
proteoglycans, specialized chemokines, and cytokines [24,25]. These growth factors influence the cell
adhesion, proliferation, and functional activity of cells [26]. PRP also contains structural constituents
of extracellular matrix (ECM) such as fibronectin, vitronectin, and thrombospondin. Furthermore,
fibronectin enhances the cell adhesion and interaction between cells [27].
Although the high activity of PRP was confirmed, there are several studies reporting its short-term
effect. In order to prolong the PRP activity and activation (by lyses) and PRP embedment (into the
matrix structures) are often used [28].
The immobilization of PRP onto the matrix led to the retention of the PRP structure, and to the
prolonging of PRP activity. As a result, the enhancement of cell proliferation and differentiation will
be extended.
Liu et al. demonstrated the nanofibers with PRP incorporated by the emulsion electrospinning
technique allowed to achieve the controlled and sustained release of growth factors (GFs) [29].
The enhancement of cell attachment and proliferation and intrinsic cartilage healing was
demonstrated [29]. However, the emulsion electrospinning of PRP and PCL leads to the limited
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effect of the PRP. This obstacle could be partially solved if water-soluble polymeric nanofibers are
used. Nevertheless, in this case, the obtained PRP-loaded nanofibers do not enable controlled release
of biomolecules, including GFs, resulting in their immediate release into media. The most prominent
effect was observed within the first 24 h of incubation [30]. Thus, the most perspective approach would
be immobilization of the PRP on the surface of plasma coated PCL nanofibers. In our previous work,
it was reported that electrospun PCL nanofibers could be coated with COOH and NH2 groups, and that
these plasma coatings improve the biocompatibility of nanofibers [31]. However, the immobilization
of the PRP on plasma-coated PCL nanofibers and its influence on the biocompatibility of prepared
nanofibrous mats has never been tested before.
The effectiveness of tissue engineering constructions depends on the type of cell and the substrate.
Many strategies employ the mesenchymal stromal cells (MSCs) as the promising candidates for cell
based therapy. Numerous studies have shown the achievement of PRP for maintaining the viability
and proliferation of bone marrow (BM) MSCs. The platelet lysate was prepared by PRP freeze/thaw
cycles showed high efficiency of maintaining MSC functions, including high cell proliferation level [32].
In the current research, the influence of different immobilization strategies of the PRP on the
surface of PCL nanofibers has been studied. It was found that PRP cannot be attached to the untreated
PCL nanofibers, while the deposition of CO2/C2H4 plasma polymers significantly improves MSC
adhesion and the immobilization efficiency of the PRP on the PCL nanofibers. Finally, the best results
were achieved for plasma coated nanofibers with covalently bonded PRP on the surface.
2. Materials and Methods
2.1. Preparation of Freeze-Platelet-Rich Plasma
Platelet-rich plasma (PRP) was prepared as described in [18,33] with minor modifications.
Blood was taken from healthy, non-smoking women after obtaining voluntary informed consent.
The blood was centrifuged in special tubes (Plasmolifting™, Moscow, Russia) and platelet-rich plasma
was collected and activated by a three freeze-thaw cycler. Plasma-derived growth factors were collected
by centrifugation at 12,000 g for 10 min at 4 ◦C, and kept frozen at −70 ◦C until further usage. Each mL
of PRP contained 102.5 mg dry matter.
All subjects gave their informed consent for inclusion before they participated in the study.
The study was conducted in accordance with the Declaration of Helsinki, and the protocol
was approved by the Ethics Committee of the Research Institude of Clinical and Experimental
Lymphology–Branch of the Institude of Cytology and Genetics, Siberian Branch of Russian Academy
of Sciences (RICEL-branch of ICG SB RAS) (Identifier: N115 from 24 December 2015).
2.2. Electrospining of Nanofibers
Nanofibrous used as substrates were prepared by electrospinning of PCL solution. The PCL
(80,000 mw, Sigma Aldrich, Darmstadt, Germany) granulated polymer was dissolved in a mixture
of acetic acid (99%, Sigma Aldrich, Darmstadt, Germany) and formic acid (98%, Sigma Aldrich,
Darmstadt, Germany). The weight ratio of acetic acid to formic acid was 2:1. The concentration of PCL
was 9 wt %. The solution was stirred for 24 h at room temperature and then the electrospinning process
was carried out using a Nanospider™ NSLAB 500 (ELMARCO, Liberec, Czech Republic). The PCL
solution was electrospun with a 20 cm long wired electrode under voltage of 55 kV. The distance
between high voltage and ground electrodes was set at 100 mm. The processing of sample is described
in our previous works [31]. The as-prepared PCL nanofibers were denoted as PCL-ref.
2.3. Deposition and Characterization of Plasma Layers
The deposition of plasma polymers was carried out using a vacuum system UVN-2M equipped
with the rotary and oil diffusion pumps providing the residual pressure in a vacuum chamber
below 10−3 Pa. The capacitively coupled radio-frequency (RF) plasma was driven by a Cito
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1310-ACNA-N37A-FF (Comet) RF power supply connected to the RFPG-128 disk generator (Beams &
Plasmas, Zelenograd, Russia), 135 mm in diameter, installed into the vacuum chamber. The RF power
and the duty cycle was set at 500 W and 5%, respectively. The deposition time was 15 min.
Ar (99.998%), CO2 (99.995%), and C2H4 (99.95%) gases were used as precursors. Gas flow control
was carried out using a Multi Gas Contoller647C (MKS, Andover, Massachusetts, USA). Working
and residual gas pressures were measured by a VMB-14 unit (Tokamak Company, Petushki, Russia)
and D395-90-000 BOC Edwards controllers (Crawley, UK). The distance between RF-electrode and
the substrate was set at 8 cm. The flow rates of Ar, CO2 and C2H4 was set to 50, 16.2 and 6.2 sccm,
respectively. The plasma coated PCL nanofibers is denoted as PCL-COOH.
The nanostructure of the nanofibers was studied by scanning electron microscopy (SEM) using
a JSM F7600 (Jeol Ltd., Tokyo, Japan) device. The SEM micrographs were obtained at an accelerating
voltage of 2 kV and a scan time of 1 min. In order to compensate the surface charging, the samples
were coated with a ~5 nm thick Pt layer by using magnetron sputtering.
The infrared spectra in the range from 4000–370 cm−1 was measured using a Fourier transform
infrared (FTIR) spectrophotometer (Bruker Vertex 80V, Ettlingen, Germany) using attenuated total
reflectance mode (ATR-FTIR). The data was collected at a pressure of 250 Pa with a resolution of 4 cm−1
and 100 scans.
The chemical composition of the sample surfaces was characterized by X-ray photoelectron
spectroscopy (XPS) using an Axis Supra (Kratos Analytical, Manchester, UK) spectrometer.
The maximum lateral dimension of the analyzed area was 0.7 mm. The spectra were fitted
using CasaXPS software (Casa Software Ltd., Teignmouth, UK) after subtracting Shirley-type
background. The binding energies (BE) for all carbon environments were employed from the
literature [31,34]. The C1s spectra of PCL-ref and PCL-COOH were fitted using the methodology
described elsewhere [31,35].
The quantification of COOH groups has been performed by well-known trifluoroethanol
(TFE, Sigma Aldrich, Darmstadt, Germany) derivatization and subsequent XPS analysis [36].
The atomic concentration of COOH groups was calculated from the amount of fluorine.
2.4. Coating of Scaffolds with PRP
In order to evaluate the adsorption of PRP to as-prepared PCL nanofibers, firstly, the PCL-ref was
immersed in PRP solution at room temperature for 15 min and then washed with Phosphate buffered
saline (PBS). The sample was denoted as PCL-P1. Afterwards, in order to evaluate the ionic bonding
of PRP to plasma coated PCL, nanofibers (PCL-COOH) were immersed in a solution of PRP for 15 min
and then washed with PBS (PCL-COOH-P2). Finally, the covalent bonding of PRP to the PCL-PP was
performed by subsequent immersing of PCL-COOH in N,N′-Dicyclohexylcarbodiimide DCC (Sigma
Aldrich, 98%, Darmstadt, Germany) solution in water (2 mg/mL) for 15 min. Washing with PBS was
followed by incubation with PRP for 15 min at room temperature and final PBS cleaning. These coated
scaffolds (denoted as PCL-COOH-P3) were finally placed in 96-well plate. Scaffolds were sterilized
under ultra-violet (UV) radiation for 45 min prior to modification by PRP.
2.5. Cell Tests
2.5.1. Cell Culture
Human mesenchymal stromal cells were extracted from bone marrow using standard methods [37]
and cultured in Dulbecco’s modified Eagle’s Medium: Nutrient Mixture F-12 (DMEM/F12,
Sigma Aldrich, Paisley PA4 9RF, UK) that was supplemented with 10% fetal bovine serum
(FBS, Gibco, Carlsbad, CA, USA). Cells were seeded in 96-well plates on scaffolds in concentration of
5 × 103 cells/well. The study was approved by the Ethics Committee of the RICEL-branch of ICG SB
RAS (No 115 from 24.12.2015).
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2.5.2. Cell Attachment
The scaffolds covered with MSCs were fixed using 4% paraformaldehyde solution for 10 min and
followed by cell membrane permeabilazation with 0.1% Triton X-100 for 15 min. Then actin filaments
of cytoskeleton were stained with Alexa fluor 532 phalloidin (Thermo Fisher Scientific, Carlsbad, CA,
USA) for 30 min. Cell nuclei were stained with Hoechst 33342. Finally, the cell adhesion on the scaffold
was observed using a fluorescence microscope (Zeiss, Axio observer Z1, Oberkochen, Germany).
2.5.3. Cell Proliferation
The rate of cellular proliferation on the samples of scaffolds was detected using the Click-iT™
EdUAlexa Fluor™ 488 Imaging Kit (Thermo Fisher Scientific, Carlsbad, CA, USA) according to the
protocol. EdU is analogue of thymidine and it is efficiently incorporated into DNA during S phase
of the cell cycle. Each scaffold was seeded with MSCs adjusted to a population of 5 × 103 cells/well
in 96-well plates. The cell-seeded scaffolds were incubated under a humidified atmosphere (5% CO2
and 95% air) at 37 ◦C. For the means of control, MSCs were cultured in 96 well plate under PRP
supplemented media at a concentration from 7 to 0.003 vol %, which is equivalent to 7.17 mg–3 µg
freeze-dried PRP/mL. At 24 and 72 h for MSC EdU was added to each sample for 2 h. Nuclear of
cells were counterstained with Hoechst 33342. The cells were observed by means of fluorescence
microscopy (Zeiss, Axio observer Z1, Oberkochen Germany) and analyzed using Cell Activision
software (Yokogawa Electric Corporation, Tokyo Japan). Cells quantity was obtained from the acquired
microscopic images (n = 50 each group). The percentage of proliferating cells was calculated as the
ratio of EdU-positive cells (green) to the total number of Hoechst-positive cells (blue).
2.5.4. Cell Apoptosis
The DNA binding fluorescent dye Hoechst 33342 was employed in order to assess the
morphological changes in apoptosis. Scaffolds cowered with MSCs were stained with Hoechst
33342 for 15 min at room temperature. Later the cells were observed with a fluorescence microscope
(Zeiss, Axio observer Z1, Oberkochen, Germany). Apoptotic cells were characterized by the means of
morphological alterations, such as condensed and fragmentation of nuclei.
For all results the mean values and associated error standard deviations were calculated.
For statistical analysis we have used Statistica 10. The p value ≤ 0.05 was considered as statistically
significant. In order to evaluate differences between groups, the nonparametric Mann-Whitney U test
was used.
3. Results
3.1. Preparation and Plasma Modification of PCL Nanofibers
The obtained results indicate that under optimal electrospinning conditions it was possible
to prepare homogenous beads-free PCL nanofibers with a diameter of 270 ± 50 nm (Figure 1a).
In a previous work, the oxygen/carbon (O/C) ratio of as-prepared PCL nanofibers (PCL-ref) measured
by XPS was equal to 0.31, which is slightly lower compared to 0.33 expected from the PCL chemical
formula [31]. The high quality of PCL nanofibers was also confirmed by typical ATR-FTIR (Figure 2a)
and XPS (Figure 3a) spectra. The C1s XPS spectrum of PCL-ref was fitted using previously reported
methodology [31]. The deposition of CO2/C2H4 plasma polymers on the surface of the nanofibers was
confirmed by ATR-FTIR (Figure 2b) and XPS (Figure 3c). After comparison of Figure 2a,c, changes in
the C=O stretching bands could be observed. XPS revealed that the structure of the C1s curves has been
significantly changed after coating by the CO2/C2H4 plasma polymer, and the structure of XPS C1s
curve depicted in Figure 3b is similar to the COOH plasma polymers deposited onto Si wafers [38,39].
The concentration of the C(O)O contribution (BE = 289 eV) equals to 11.3 at %, but this carbon
contribution includes both esters and carboxyl functions. According to XPS, derivatization density of
the COOH groups was performed the derivatization of CO2/C2H4 plasma polymers deposited on
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Si wafers, as the derivatization of carboxylic groups using the reaction with trifluoroethanol (TFE) is
not applicable for PCL nanofibers due to dissolution of PCL in TFE. The derivatization of the COOH
groups on the CO2/C2H4 plasma polymers deposited onto Si wafers in the same conditions revealed
that this layer bears 0.57 at % of COOH groups. It could be considered that the same amount of COOH
groups was deposited on the PCL nanofibers. Regarding the morphology, SEM analysis revealed that
it was not influenced by the deposition of the plasma polymerized layer (Figure 1c).
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(d) and PCL-COOH-P3 (e).
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Figure 3. X-ray photoelectron spectroscopy (XPS) C1s spectra of as-prepared nanofibers PCL-ref (a);
PCL-COOH (b) and PCL-COOH-P3 (c).
Polymers 2017, 9, 736 8 of 14
3.2. Immobilization of PRP onto PCL Nanofibers
According to ATR-FTIR results presented in Figure 2b, the immersion of PCL-ref in PRP solution
has no effect on the layer chemistry of PCL nanofibers, i.e., no PRP immobilization was been
demonstrated. On the contrary, the immersion of plasma coated PCL-COOH in PRP solution led to
significant changes in the layer chemistry. First of all, it was found that new peaks located at 1652
and 1598 cm−1 attributed to C=O stretching and NH2 bending of amides, respectively (Figure 2d,e).
These new peaks confirm the incorporation of the molecules with peptide bonds.
Moreover, XPS analysis revealed that the PCL-COOH composed of 72.1 at % of carbon and
27.9 at % of oxygen. The immobilization of PRP though ionic bonds (PCL-COOH-P2) led to the
incorporation of significant concentration of nitrogen (10.7 at %), whereas the concentration of carbon
and oxygen were 70.5 and 18.8 at %, respectively. The immobilization of PRP via covalent bonding
(PCL-COOH-P3) led to similar composition of the surface: [C] = 76.5 at %, [O] = 16.3 at % and
[N] = 7.2 at %. The XPS C1s signal of PCL-COOH-P3 was fitted using four carbon environments as
described elsewhere [10]. The C1s XPS curve fitting revealed significant changes in carbon environment
after immobilization of PRP (Figure 3c). The concentration of the C(O)O environment decreased while
new contribution corresponding to the amides (N–C=O, BE = 288 eV) appeared. This observation
confirms that the biomolecules with protein nature was grafted onto the surface. It is worth noting
that according to SEM micrographs, the PCL-P1 exhibited same morphology as PCL-ref (Figure 1a,b).
In contrast, the immobilization of PRP on PCL-COOH led to significant modification of PCL nanofibers
morphology. Irrespective of the nature of bonding (ionic or covalent), the pores of nanofibrous
mats became smaller due to the immobilization of PRP. Nevertheless, both PCL-COOH-P2 and
PCL-COOH-P3 exhibited nanofibrous structures similar to ECM.
3.3. Cell Adhesion Test
The first stage of the biocompatibility evaluation of the scaffolds was the investigation of the cell
adhesion to the surface of the prepared PCL-ref and modified nanofibers PCL-COOH, PCL-COOH-P2
and PCL-COOH-P3.
It was found that after 3 h, the MSCs seeded on PCL-ref exhibited weak coloring of the
cytoskeleton. The adhesion contacts of cells with the surface of the PCL-ref was very weak.
Cells attempted to adhere to the hydrophobic surface, leading to the formation of the lamellipodia
and actin-rich filopodia (Figure 4). However, the absence of a good contact with the PCL-ref surface
affected the survival and proliferation of MSCs, and the majority of cells did not survive on PCL-ref
after 72 h.
The adhesion of MSC cells to the PCL-COOH and PCL-COOH-P2 was characterized by smaller
spreading area, but the cells formed adhesion contacts. The cells had significantly well-defined network
of actin filaments (Figure 4). It has been observed that the MSCs on PCL-COOH-P3 exhibited very
good spreading and very meaningful actin-rich contacts with the surface as well as defined network
of stress-fibrils. It is worth noting that the Hoechst/Phalloidin staining of the PCL-ref led to the very
noisy background on the picture due to interaction of the dye with the hydrophobic PCL nanofibers.
Thus, in order to provide better quality images, the cells on PCL-ref were stained with Phalloidin only.
Hence, it was shown that the adhesion of MSCs to the modified surfaces (PCL-COOH,
PCL-COOH-P2 and PCL-COOH-P3) resulted in the formation of the significant actin-rich cytoskeleton,
which is an important compound for cell viability and fitness. It is well-known that PRP contains adhesive
protein-fibronectin, and this protein enhances cell adhesion, migration, and proliferation. Moreover,
fibronectin participate in the control of cell differentiation, and cytoskeleton sustainability [16].
The best cell adhesion results were observed for PCL-COOH-P2 and PCL-COOH-P3, which can
be explained by a high amount of PRP fibronectin at its surface.
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Figure 4. Adhesion of mesenchymal stro al cells (MSCs) on the surface of PCL-ref (A); PCL-COOH
(B); PCL-COOH-P2 (C) and PCL-COOH-P3 (D). The actin filaments of cytoskeleton are stained by
Phalloidin (red) while the cell nucleus is stained by Hoechst 33342 (blue). All images shown at ×40
magnification and the size of the bar corresponds to 50 µm.
3.4. Influence of the Surface Modification on the Proliferation of MSCs
The influ nce of PRP immobilization on the proliferation of the adhered hum n MSCs is
demonstrated in Figures 5 and 6. After 24 h, t highest percentage of proliferating cells (equal
to 50 ± 1.7%) has been recorded for PCL-COOH-P3, where the PRP biomolecules have covalent
bonding to the scaffold surface. Control cells were cultivated on plastic plates in media supplemented
with PRP in range concentration from 7 to 0.8 vol % demonstrated the proliferation rate comparable
PCL-COOH-P3 (51.8%–49.7%).
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Figure 5. Influence of surface modificati f a fibers on proliferation and viability of human
MSCs. (a) the percentage of proliferating cells after 24 and 72 h of cultivation (calc l t t ti of
EdU-positive cells to the total number of H echst-positive cells); (b aver g number of cells for single
bright-field imag after 24 and 7 h of cultivation. Data are expressed as mean ± standard deviation.
** p < 0.01, ** p < 0.05.
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Figure 6. Influence of surface modification of PCL-ref (A); PCL-COOH (B); PCL-COOH-P2 (C) and
PCL-COOH-P3 (D) nanofibers on proliferation and viability of human MSCs. The cell nucleus is stained
by DNA binding fluorescent dye Hoechst 33342 (blue), the proliferating cells stained by EdUAlexa
Fluor™ 488 (green). All images shown at ×20 magnification.
The proliferatio on PCL-COOH-P2, wh e biomo ecules have ionic bonding with the surface,
was also very high and the per ntage of proliferati g cells was equa to 44 ± 2.7%. At the same
time, the percenta e of proliferati g cells on PCL-COOH an PCL-ref was only 20 ± 3.4% and
6 ± 0.8%, respectively. The good a hesion and active cell proliferation led to high average number
of cells counted from a single bright-field image (91 ± 4.8 cells for PCL-COOH-P3 and 78 ± 4.2 for
PCL-COOH-P2), while the number of cells on PCL-COOH and PCL-ref was lower (22 ± 1.8 and
16 ± 0.9, respectively).
Nevertheless, remarkably high level of proliferation on PCL-COOH-P3 occurred after 24 h, and the
proliferation slowed down after 72 h, due to contact inhibition (normal cells stop growing when they
reach confluence) (Figures 5 and 6). On PCL-COOH, the density of the cell culture was lower and
the proliferation level after 72 h was the highest (11%). Cells on PCL-ref scaffold stopped dividing
after 72 h. These samples exhibited very high average number of cells: 258 ± 12.9 and 364 ± 34.5 for
PCL-COOH-P2 and PCL-COOH-P3, respectively, as a result of active proliferation and sustaining the
cell viability on nanofibers with immobilized PRP. The average cell number on PCL-COOH was only
98 ± 8, whereas PCL-ref exhibited only single viable cells (Figures 5 and 6).
3.5. Influence of The Surface Modification on the Viability of MSCs
The percentage of apoptotic cells was determined by staining of the cell nucleus by Hoechst
33342. It was found that after 24 h, 23 ± 5% nuclei adhered to PCL-ref and showed some features
of apoptosis, e.g., fragmentation of the nucleus and condensation of chromatin, which is shown in
Figure 6. In contrast, the modified PCL nanofibers exhibited low percentages of apoptotic/death cells
(1 ± 0.06%) (Figure 7).
Aft r 72 h the number of apoptotic cells on PCL-COOH-P2 and PCL-COOH-P3 did not increase
in spite of full confluenc of cells. At the same time, the percentages of apoptotic cells on PCL-ref
exceeded 50%.
It could be concluded that the deposition of plasma layers combined with immobilization of
PRP enhances the viability and proliferation of human MSCs. The covalent binding of PRP leads to
extension of this effect compared to the ionic bonding of PRP. The PCL-COOH-P3 exhibited the total
cell number 1.5 times higher compared to PCL-COOH-P2.
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Therefore, the immobilization of PRP onto PCL nanofibers leads to a significant increase in the
number of adhered cells, and an increase of the density of the cell population and proliferation level,
and a decrease in apoptotic/dead cells.
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Figure 7. Representative picture of apoptosis analysis. The morphology of MSCs nucleus after 24 h.
The PCL-COOH-P3 (a) exhibited homogenous form and coloration of the nucleus and no condensation
of the chromatin; whereas cells grown on PCL-ref (b) exhibited the chromatin condensation and nuclear
fragmentation (kariorhexis) (yellow arrows). Magnification ×40.
However, the ionic bonding of PRP to PCL-COOH demonstrated less effect on proliferation level
enhancement although XPS analysis of PCL-COOH-P2 and PCL-COOH-P3 after 72 h of immersion
in water revealed the same composition of the surface (within XPS error margins), i.e., the bonding
of proteins, even via ionic linkage is strong. The influence of the nature of the linkage between the
PRP and PCL-COOH will to be further studied in future using mass spectra analysis (e.g., by Matrix
Assisted Laser Ablation Time-of-Flight mass spectrometry).
High proliferation rate, low percentage of apoptotic cells death, contact inhibition of proliferation
MSCs on substrates with PRP suggests that the investigated scaffold provides conditions for normal
cell function. Immobilization of the PRP on plasma coated PCL nanofibers used in this investigation is
a promising technique to modification of surface properties for enhancement of biological activity of
tissue engineering scaffolds.
Thus we have shown developed a functional ECM mimicking scaffold that is capable of
consolidating platelet-derived growth factors thereby to supply adhesion and high proliferation
of MSCs.
4. Conclusions
The immobilization of platelet-rich plasma (PRP) onto plasma coated polycaprolactone (PCL)
nanofibers significantly improves cell adhesion, boosts cell proliferation and viability. It was shown
that the plasma coating solely can enhance the biocompatibility of the PCL nanofibers, but in this case
the level of cell proliferation is dramatically lower compared to the PCL nanofibers with immobilized
PRP. The immobilization of the PRP to the plasma coated PCL-COOH can be easily used by soaking
in a solution of PRP. Our results have shown that the bonding of PRP (ionic or covalent) influences
the cell proliferation level and cell viability. The in vitro tests of plasma-coated PCL nanofibers with
covalently immobilized PRP showed best performance, and this material is highly promising for
tissue engineering.
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